ArticleESMO open2022

Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials.

E Dell'Aquila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.